Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
E-cigarettes and Tobacco Cigarettes Induce Similar Acute Respiratory Response
05/15/2019
Short-term respiratory responses to use of e-cigarettes and tobacco cigarettes are similar, researchers say.
Short-term respiratory responses to use of e-cigarettes and tobacco cigarettes are similar, researchers say.
Short-term respiratory responses...
05/15/2019
Pharmacy Learning Network
News
FDA Advisory Panel Votes Against Daiichi Sankyo`s Blood Cancer Treatment
05/14/2019
The panel voted 8-3 against the drug, quizartinib, after assessing data presented by the drug company.
The panel voted 8-3 against the drug, quizartinib, after assessing data presented by the drug company.
The panel voted 8-3 against the...
05/14/2019
Pharmacy Learning Network

Advertisement

News
Do All Statin Users Reach Healthy LDL-C Levels?
05/14/2019
“The proportions of patients not achieving threshold LDL-C levels indicate an unmet preventive need,” the researchers wrote.
“The proportions of patients not achieving threshold LDL-C levels indicate an unmet preventive need,” the researchers wrote.
“The proportions of patients not...
05/14/2019
Pharmacy Learning Network
News
Without Heart Disease, Daily Aspirin May Be Too Risky
05/13/2019
A new study suggests that taking a daily aspirin to prevent heart attacks and strokes may increase the risk of severe intracranial bleeding to the point where the risk outweighs any potential benefit.
A new study suggests that taking a daily aspirin to prevent heart attacks and strokes may increase the risk of severe intracranial bleeding to the point where the risk outweighs any potential benefit.
A new study suggests that taking...
05/13/2019
Pharmacy Learning Network
News
Only 13% of Patients Eligible for Checkpoint Inhibitors Respond to Them
05/13/2019
About 44% of cancer patients may be eligible for an FDA-approved checkpoint inhibitor drug, yet approximately 13% will respond to them, researchers say.
About 44% of cancer patients may be eligible for an FDA-approved checkpoint inhibitor drug, yet approximately 13% will respond to them, researchers say.
About 44% of cancer patients may...
05/13/2019
Pharmacy Learning Network

Advertisement

News
Opioid Overdose Deaths Decline When Pharmacists Can Dispense Naloxone
05/09/2019
According to a new study, in states where pharmacists were allowed to sell the opioid antidote naloxone without a prescription, fewer people died from opioid overdoses.
According to a new study, in states where pharmacists were allowed to sell the opioid antidote naloxone without a prescription, fewer people died from opioid overdoses.
According to a new study, in...
05/09/2019
Pharmacy Learning Network
News
Recall Active for Bevacizumab
05/09/2019
The FDA has issued a recall for a biologic medication used in the treatment of numerous cancers, including kidney, cervical, ovarian, colon, and rectal cancer.
The FDA has issued a recall for a biologic medication used in the treatment of numerous cancers, including kidney, cervical, ovarian, colon, and rectal cancer.
The FDA has issued a recall for...
05/09/2019
Pharmacy Learning Network
News
Class II Recall Active for Hydromorphone
05/09/2019
The FDA is recalling a narcotic medication used to relieve pain.
The FDA is recalling a narcotic medication used to relieve pain.
The FDA is recalling a narcotic...
05/09/2019
Pharmacy Learning Network

Advertisement

News
Diabetes Drug Recalled
05/09/2019
A prescription medication used to control blood sugar levels in people with type 2 diabetes is being recalled.
A prescription medication used to control blood sugar levels in people with type 2 diabetes is being recalled.
A prescription medication used...
05/09/2019
Pharmacy Learning Network
News
Four Firms Issue New Recalls for Losartan
05/09/2019
A Class II recall is active for a prescription angiotensin receptor blocker used to treat high blood pressure and to protect kidneys from diabetes-related damage.
A Class II recall is active for a prescription angiotensin receptor blocker used to treat high blood pressure and to protect kidneys from diabetes-related damage.
A Class II recall is active for...
05/09/2019
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use